text: <unk>  is an antimanlaric that is FDA approved for the treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients of 5 kg bodyweight and above.   Common adverse reactions include headache, anorexia, dizziness, asthenia, arthralgia and myalgia.
option_0: Artemether and lumefantrin
option_1: Artemether/lumefantrine
option_2: Thonzylamine hydrochloride and chlophedianol hydrochloride
option_3: Atovaquone and proguanil hydrochloride
option_4: Methenamine and sodium salicylate
option_5: Sodium sulfate, potassium sulfate and magnesium sulfate
option_6: Galantamine hydrobromide
option_7: Streptozocin